GENE ONLINE|News &
Opinion
Blog

Special
The First International Biomedical Entrepreneurship Competition Has Announced Its Top 6 Winners
2022-05-23
RNA Therapeutics Beyond Vaccines
2022-05-19
Financial Times’ US Pharma Biotech Summit 2022: Track & Invest in American Life Sciences
2022-05-16
The FDA Issued its First Formal Warning to Companies Selling Delta-8 THC Products
2022-05-05
APCM 2022: Precision Medicine Is Opening Up a New Prospect of Cancer Therapy
2022-05-04Partner
All Blue Capital Recruits Former AstraZeneca Oncology Head to Sweeten Zymeworks Deal
2022-05-04
Spero Therapeutic Lays Off 75% of Employees Resulting in Stock Plummet
2022-05-04
Bio-Europe Spring: 2022 Europe Ophthalmic Medication Market Skyrockets
2022-04-20
Refining Psychedelics into Medicine – An Interview with Doug Drysdale, CEO of Cybin
2022-04-19
AACR 2022: Raising Capital for Drugs of the Future- Cell Therapies
2022-04-18
Single Cell Sequencing Uncovers How Early Embryonic Cells Differentiate
2022-04-13
The Renaissance of Psychedelics Research: An Interview with the CEO of MindMed, Rob Barrow
2022-04-12
How to Break into the Digital Health Market in the UK – An Interview with Professor Sudhesh Kumar
2022-03-25
WSJ Health Forum 2022: Psychedelics Set to Take Center Stage in Mental Wellness
2022-03-24
Low Doses of LSD as a Potential Treatment for Anxiety in the Future?
2022-03-22
1 10 11 12 13 14 20
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top